Striant Lawsuits may be available to men who had a pulmonary embolism after using this popular testosterone supplement. In recent months, a pair of independently-conducted scientific studies determined that testosterone boosters like striant significantly increase users’ risk of suffering adverse cardiovascular health consequences. Symptoms of a Striant Pulmonary Embolism include chest pain, breathing problems, cyanosis, and leg cramping.
Free Confidential Lawsuit Evaluation: If you or a loved one suffered a pulmonary embolism after using Striant, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Striant and we can help.
What is Striant?
Striant is prescribed to treat testosterone deficiency, which can take a toll on a man’s muscle mass, sex drive, and energy levels. This medical condition, which may be referred to as hypogonadism, causes diminished strength and energy levels, in addition to reduced sexual function. However, recent studies have found that patients taking Striant or other testosterone replacement therapy (TRT) drugs may not actually have real need for the products, and may instead be placing themselves at risk of developing a number of adverse (in some cases life-threatening) health complications.
Striant & Pulmonary Embolism
A January 2014 study published in PLOS ONE determined that testosterone supplements like Striant double the heart attack risk in men aged 65 or older, and triple the risk in younger men with a history of heart problems. In November 2013, another study published in the Journal of the American Medical Association (JAMA) found a nearly 30% increased risk of heart attack in the three months after starting treatment with testosterone boosters. Considering the findings of these studies, it appears likely that the health risks associated with Striant outweigh any potential benefits.
One of the earliest studies to investigate the risk of pulmonary embolism in testosterone users came out in October 2011 in the journal Translational Research. Dr. Charles Glueck, a cardiology specialist at the Jewish Hospital Cholesterol and Metabolism Center in Cincinnati, found numerous incidences of pulmonary embolism in patients treated with testosterone, the vast majority of cases resulting from previously-undiagnosed blood clot risk factors, which approximately 5% of American men are estimated to have.
What is a Pulmonary Embolism?
A pulmonary embolism (PE) occurs when one of the arteries leading to the lungs becomes blocked. In most cases of PE, the block is the result of a blood clot that travels to the lung from a vein in the leg. A Striant pulmonary embolism is severe medical emergency that can result in:
- Damage to the lung tissue, which may cause pulmonary hypertension, or increased pressure in the pulmonary arteries.
- Decreased oxygen levels in the blood.
- Injury to other organs due to a lack of oxygenated (red) blood.
It has been estimated that up to a half million Americans suffer a pulmonary embolism each year. If untreated, approximately 1/3 of patients with PE will die (most often within hours of sustaining the injury). However, with a prompt diagnosis and effective medical treatment, the condition is survivable.
Do I Have a Striant Pulmonary Embolism Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Striant Lawsuits. We are handling individual litigation nationwide and currently accepting new Striant pulmonary embolism cases in all 50 states.
Free Striant Pulmonary Embolism Lawsuit Evaluation: If you or a loved one suffered a pulmonary embolism after taking Striant, you should contact our law firm immediately. You may be entitled to compensation by filing a Striant Pulmonary Embolism Suit and we can help.